Question 1

Does Ubs own KYTX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Ubs holds 365,574 shares of KYTX (Kyverna Therapeutics), worth $3.3M.

Question 2

How many shares of KYTX does Ubs own?

Accepted Answer

As of its Q2 2026 13F, Ubs holds 365,574 shares of KYTX (Kyverna Therapeutics).

Question 3

What is Ubs' KYTX position worth?

Accepted Answer

As of its Q2 2026 13F, Ubs' KYTX position is worth $3.3M.

Question 4

Is Ubs buying or selling KYTX?

Accepted Answer

In Q2 2026, Ubs reduced its KYTX position by 84,176 shares (-18.7%).

Question 5

When did Ubs first buy KYTX?

Accepted Answer

Ubs already held KYTX in its Q1 2024 13F, the earliest on record, and has listed it in 10 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	365,574	-18.7%	$3.3M	0.0%	$8.91	0
2026-Q1	Increased	449,750	+122.4%	$3.9M	0.0%	$8.63	43
2025-Q4	Increased	202,187	+28.4%	$1.9M	0.0%	$9.40	32
2025-Q3	Increased	157,422	+60.4%	$944,532	0.0%	$6.00	36
2025-Q2	Decreased	98,158	-44.8%	$301,345	0.0%	$3.07	0
2025-Q1	Decreased	177,670	-12.7%	$342,903	0.0%	$1.93	0
2024-Q4	Increased	203,403	+2381.7%	$760,727	0.0%	$3.74	40
2024-Q3	Decreased	8,196	-15.0%	$40,078	0.0%	$4.89	0
2024-Q2	Decreased	9,644	-61.3%	$72,330	0.0%	$7.50	0
2024-Q1	New	24,898	-	$618,466	0.0%	$24.84	34

KYTX10 quarters

KYTX
10 quarters